Taro Recalls Clotrimazole Cream Due to Unknown Degradation Impurity
Taro Pharmaceuticals is recalling CVS Health Athlete's Foot Cream because an unknown degradation impurity was detected slightly above the specification limit.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, which maps to a severity score of 4 (Severe) per the rubric, as it indicates a risk of temporary or medically reversible adverse health consequences.
Plain-English summary
Taro Pharmaceuticals U.S.A., Inc. is recalling 64,692 1-ounce tubes of CVS Health Athlete's Foot Cream, Clotrimazole Cream USP, 1%. The product is identified by Lot # A873430336 and an expiration date of December 2020. It was distributed nationwide in the USA and Canada.
The recall was initiated because an unknown degradation impurity was detected slightly above the specification limit in the product. This is a Class II recall, indicating a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences.
Consumers should stop using the recalled product and return it to the place of purchase for a refund or contact the recalling firm for further instructions.
The recalled product
- Product
- CLOTRIMAZOLE 1% (CLOTRIMAZOLE)
- Brand
- CLOTRIMAZOLE 1%
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Category
- Drug — Topical Antifungal
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: A873430336
- Exp Dec-2020
UPCs (1)
- 0050428367933
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Taro Pharmaceuticals U.S.A., Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Taro Pharmaceuticals U.S.A., Inc.
See all →- ModerateHydrocortisone & Acetic Acid Otic Solution Recalled for Potency and Impurity Failures
FDA (Drugs) · 2024-08-21
- ModerateClotrimazole and Betamethasone Topical Cream Recalled for Failed Potency Specifications
FDA (Drugs) · 2022-04-06
- SevereClobetasol Propionate Ointment Recalled for Microbial Contamination
FDA (Drugs) · 2022-01-19
- HighTaro Recalls Nortriptyline Hydrochloride Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2021-02-10
- ModerateTaro Recalls Rite Aid Clotrimazole Cream Due to Impurity
FDA (Drugs) · 2020-12-23
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17